Metraipolis › archive › dc_09ec07e39152

Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery — Europe PMC PMID:33556101

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33556101
DOI
10.1371/journal.pone.0246299
License (as archived)
CC0-1.0
Archived
2026-11-05T23:35:06.389Z
SHA-256 of the archived text
7d25901da999684334bf35ad758c8e228fd692d836fff9acca02f60a966f2f1c
Stable URL of this page
https://metraipolis.com/documento/dc_09ec07e39152

How to cite

Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery — Europe PMC PMID:33556101 — Europe PMC (en), https://europepmc.org/article/MED/33556101 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_09ec07e39152 (Metraipolis archive dc_09ec07e39152, sha256 7d25901da999684334bf35ad758c8e228fd692d836fff9acca02f60a966f2f1c)
BibTeX
@misc{dc09ec07e39152,
  title = {Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery — Europe PMC PMID:33556101},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33556101},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_09ec07e39152; sha256 7d25901da999684334bf35ad758c8e228fd692d836fff9acca02f60a966f2f1c},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33556101. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Extracorporeal cytokine adsorption is an option in septic shock as an additional measure to treat a pathological immune response. Purpose of this study was to investigate the effects of extracorporeal cytokine adsorption on hemodynamic parameters in patients with acute kidney injury (AKI) on continuous renal replacement therapy (CRRT) and septic shock after cardiac surgery. Methods: In this retrospective study, a total of 98 patients were evaluated. Hemoadsorption was performed by the CytoSorb® adsorber. In all patients cytokine adsorption was applied for at least 15 hours and at least one adsorber was used per patient. To compare cumulative inotrope need in order to maintain a mean arterial pressure (MAP) of ≥ 65 mmHg, we applied vasoactive score (VAS) for each patient before and after cytokine adsorption. A paired t-test has been performed to determine statistical significance. Results: Before cytokine adsorption the mean VAS was 56.7 points. This was statistically significant decreased after cytokine adsorption (27.7 points, p< 0.0001). Before cytokine adsorption, the mean noradrenalin dose to reach a MAP of ≥ 65 mmHg was 0.49 μg/kg bw/min, the mean adrenalin dose was 0.12 μg/kg bw/min. After cytokine adsorption, significantly reduced catecholamine doses were necessary to maintain a MAP of ≥ 65 mmHg (0.24 μg/kg bw/min noradrenalin; p< 0.0001 and 0.07 μg/kg bw/min adrenalin; p < 0.0001). Moreover, there was a significant reduction of serum lactate levels after treatment (p< 0.0001). The mean SOFA-score for these patients with septic shock and AKI before cytokine adsorption was 16.7 points, the mean APACHE II-score was 30.2 points. The mean predicted in-hospital mortality rate based on this SOFA-score of 16.7 points was 77,0%, respectively 73,0% on APACHE II-score, while the all-cause in-hospital mortality rate of the patients in this study was 59.2%. Conclusion: In patients with septic shock and AKI undergoing cardiac surgery, extracorporeal cytokine adsorption could significantly lower the need for postoperative inotropes. Additionally, observed versus SOFA- and APACHE II-score predicted in-hospital mortality rate was decreased.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-02-08).
Identificativi: PMID 33556101 · PMCID PMC7870055 · DOI 10.1371/journal.pone.0246299.
Pagina: https://europepmc.org/article/MED/33556101 — https://doi.org/10.1371/journal.pone.0246299. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-05T23:31:42.283Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.